Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
766
-
Total 13F shares, excl. options
-
199M
-
Shares change
-
+3.51M
-
Total reported value, excl. options
-
$5.56B
-
Value change
-
+$114M
-
Put/Call ratio
-
0.54
-
Number of buys
-
299
-
Number of sells
-
-371
-
Price
-
$27.93
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q4 2022
855 filings reported holding OGN - Organon & Co. - Common Stock as of Q4 2022.
Organon & Co. - Common Stock (OGN) has 766 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 199M shares
of 260M outstanding shares and own 76.42% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (31.5M shares), BlackRock Inc. (16.4M shares), Mawer Investment Management Ltd. (13.2M shares), STATE STREET CORP (12.9M shares), JANUS HENDERSON GROUP PLC (12M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (7.54M shares), LORD, ABBETT & CO. LLC (7.46M shares), GEODE CAPITAL MANAGEMENT, LLC (5.85M shares), Bank of New York Mellon Corp (5.49M shares), and Invesco Ltd. (4.47M shares).
This table shows the top 766 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.